Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2026. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main resolutions, for further details please refer to the notice available on the […]

Stockholm – April 15, 2026 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and diagnostics, hereby invites its shareholders to Annual General Meeting on May 20, 2026. Please find attached the invitation including agenda and details on how to register and vote. The invitation is also available on the company’s website: […]

Today, December 4, 2025, an extraordinary general meeting was held in INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"). At the meeting, 66,655,976 shares were represented, corresponding to 84.5 per cent of the total number of shares and votes in the Company. Below follows a summary of the resolution adopted at the meeting. Resolution on […]

Stockholm – November 12, 2025 – Inify Laboratories AB (publ), a unique laboratory service that provides cancer diagnostics within pathology, hereby invites its shareholders to Extraordinary General Meeting on December 4, 2025. Please find attached the invitation including attachment, agenda and details on how to register and vote. The invitation is also available on the […]

STOCKHOLM – November 12, 2025 – Inify Laboratories AB ("Inify" or the "Company") will in a separate press release call for an extraordinary general meeting (the "EGM") to be held on December 4, 2025 at 10:00 CET to resolve on a fully guaranteed share issue of a total of 28,571,429 new shares generating gross proceeds of […]

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2025. A total of 44,461,934 shares were represented at the Annual General Meeting, corresponding to 56,35% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board […]

Stockholm – April 16, 2025 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May 20, 2025. Please find attached the invitation including agenda and details on how to register and vote. The invitation is also available on the company’s […]

Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordinary general meeting. A total of 28,168,336 shares were represented at the general meeting, which corresponds to 62.3 percent of the total number of shares and votes in the Company. Below is a summary of the resolution that were made. The […]

STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify” or the “Company”) on 23 October 2024 regarding expansion to the UK and a potential share issue of approximately SEK 150 million. The Company will in a separate press release call for an Extraordinary General […]

Stockholm – November 15, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Extraordinary General Meeting on December 6, 2024. Please find attached the invitation including attachment, agenda and details on how to register and vote. The invitation is also available on the […]